BibTex RIS Cite

Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market

Year 2015, Volume: 5 Issue: 3, 141 - 153, 01.09.2015

Abstract

The objective of this study is to analyze the evolution of dynamic capabilities in the discovery cycle of an innovation in the pharmaceutical market of erectile dysfunction in the period of twenty years. To achieve this, two distinct and complementary concepts were applied: models of March (1991) to exploitative and explorative discovery in the organizational learning process and the three components of dynamic capabilities. The result showed that the components of the capabilities may be identified in the discovery cycle of Viagra®. The study confirms the existence of a stock of knowledge among the companies in the pharmaceutical market of erectile dysfunction as well as a large absorptive capacity among all of them.

Year 2015, Volume: 5 Issue: 3, 141 - 153, 01.09.2015

Abstract

There are 0 citations in total.

Details

Other ID JA37SR72BE
Journal Section Research Article
Authors

Claudimar Pereira Da Veiga This is me

Cássia Rita Pereira Da Veiga This is me

Mônica Maier Giacomini This is me

Heitor Takashi Kato This is me

Jansen Maia Del Corso This is me

Publication Date September 1, 2015
Published in Issue Year 2015 Volume: 5 Issue: 3

Cite

APA Veiga, C. P. D., Veiga, C. R. P. D., Giacomini, M. M., Kato, H. T., et al. (2015). Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market. International Review of Management and Marketing, 5(3), 141-153.
AMA Veiga CPD, Veiga CRPD, Giacomini MM, Kato HT, Corso JMD. Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market. IRMM. September 2015;5(3):141-153.
Chicago Veiga, Claudimar Pereira Da, Cássia Rita Pereira Da Veiga, Mônica Maier Giacomini, Heitor Takashi Kato, and Jansen Maia Del Corso. “Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market”. International Review of Management and Marketing 5, no. 3 (September 2015): 141-53.
EndNote Veiga CPD, Veiga CRPD, Giacomini MM, Kato HT, Corso JMD (September 1, 2015) Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market. International Review of Management and Marketing 5 3 141–153.
IEEE C. P. D. Veiga, C. R. P. D. Veiga, M. M. Giacomini, H. T. Kato, and J. M. D. Corso, “Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market”, IRMM, vol. 5, no. 3, pp. 141–153, 2015.
ISNAD Veiga, Claudimar Pereira Da et al. “Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market”. International Review of Management and Marketing 5/3 (September 2015), 141-153.
JAMA Veiga CPD, Veiga CRPD, Giacomini MM, Kato HT, Corso JMD. Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market. IRMM. 2015;5:141–153.
MLA Veiga, Claudimar Pereira Da et al. “Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market”. International Review of Management and Marketing, vol. 5, no. 3, 2015, pp. 141-53.
Vancouver Veiga CPD, Veiga CRPD, Giacomini MM, Kato HT, Corso JMD. Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market. IRMM. 2015;5(3):141-53.